Double transplant strategy tested against rare, deadly leukemia
NCT ID NCT02858999
Summary
This study tested an intensive treatment approach for primary plasma cell leukemia, a rare and aggressive form of blood cancer with very poor survival rates. Forty patients under age 70 received strong chemotherapy followed by stem cell transplants, with some receiving two transplants. The goal was to see if this aggressive approach could better control the disease and extend survival compared to standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP-HP
Paris, 75004, France
-
CH Dunkerque
Dunkirk, 59385, France
-
CH Pays d'Aix
Aix-en-Provence, 13616, France
-
CHRU Lille
Lille, 59037, France
-
CHU Amiens
Amiens, 80054, France
-
CHU Besançon
Besançon, 25030, France
-
CHU Caen
Caen, 14033, France
-
CHU Clermont Ferrand
Clermont-Ferrand, 63003, France
-
CHU Dijon
Dijon, 21034, France
-
CHU Nancy
Nancy, 54035, France
-
CHU Nantes
Nantes, 44093, France
-
CHU Nice
Nice, 06003, France
-
CHU Poitiers
Poitiers, 86021, France
-
CHU Rennes
Rennes, 35033, France
-
CHU Strasbourg
Strasbourg, 67091, France
-
CHU Toulouse
Toulouse, 31059, France
-
CHU Tours
Tours, 37044, France
-
Hospices Civils de Lyon
Lyon, 69229, France
Conditions
Explore the condition pages connected to this study.